FDA Webinar on In Silico Medicine August 9
The U.S. Food and Drug Administration (FDA) will present a webinar on “What We’re Doing to Advance In Silico Medicine at FDA.” Tina Morrison, Ph.D., chair of FDA’s Modeling and Simulation Working Group and Regulatory Advisor of Computational Modeling for FDA’s Office of Device Evaluation will give an overview of in silico modeling and simulation approaches used by FDA. Her presentation will highlight success stories with simulation and discuss the potential for in silico clinical trials for advancing medical products.
The webinar will be presented on Thursday, August 9, from noon-1:00 p.m. EDT. Continuing education credit is available for viewing the webinar.